首页> 美国政府科技报告 >THE CALCULATION OF TREATMENT SCHEDULES FOR CANCER CHEMOTHERAPY. PART II,

【24h】

THE CALCULATION OF TREATMENT SCHEDULES FOR CANCER CHEMOTHERAPY. PART II,

机译：癌症化疗治疗方案的计算。第二部分，

获取原文

页面导航

著录项
相似文献
相关主题

著录项

作者
stuart, r. n. merkle, t. c.;
展开▼
作者单位

展开▼
年度 1966
页码 1-26
总页数 26
原文格式 PDF
正文语种 eng
中图分类工业技术;
关键词
chemotherapeutic agents; scheduling; cancer; chemotherapyucrl-14505;

机译：化学治疗剂;调度;癌症;化疗药物-14505;

相似文献

外文文献
中文文献
专利

1. A randomised phase III trial comparing consolidation treatment with further chemotherapy to chest irradiation in patients with initially unresectable locoregional non-small-cell lung cancer responding to induction chemotherapy. European Lung Cancer W [J] . Sculier JP, Paesmans M, Lafitte JJ, Annals of oncology: official journal of the European Society for Medical Oncology . 1999,第3期

机译：一项随机III期试验，比较了对于最初无法切除的局部区域非小细胞肺癌对诱导化疗有反应的患者，将巩固治疗与进一步化疗与胸部放疗进行了比较。欧洲肺癌W
2. Phase II prospective study of the efficacy of gefitinib for the treatment of stage III/IV non-small cell lung cancer with EGFR mutations, irrespective of previous chemotherapy. [J] . Sunaga N, Tomizawa Y, Yanagitani N, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2007,第3期

机译：吉非替尼治疗EGFR突变的III / IV期非小细胞肺癌的疗效的II期前瞻性研究，与以前的化疗无关。
3. Non-surgical care for locally advanced breast cancer: radiologically assessed therapeutic outcome of a new enzyme-targeting radiosensitization treatment, Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas, Type II (KORTUC II) with systemic chemotherapy. [J] . Miyatake K, Kubota K, Ogawa Y, Oncology reports . 2010,第5期

机译：局部晚期乳腺癌的非手术治疗：一项针对新酶靶向放射增敏治疗的放射学评估的治疗结果，即针对全身性化学疗法的II型高知不能切除的癌的高知Oxydol放射疗法（KORTUC II）。
4. Results of treatment of the patients with II~(nd)-III~(rd) st. breast cancer by combination of low level laer therapy (LLLT) and surgery (10-year experience) [C] . V.A.Mikhailov, I.N.Densiov, G.A.Frank, Conference on Laser Florence'99: A Window on the Laser Medicine World 28-31 October 1999 Florence, Italy . 1999

机译：II〜（nd）-III〜（rd）st患者的治疗结果。低水平激光疗法（LLLT）和手术相结合的乳腺癌（10年经验）
5. The Association of Hospital and Patient Characteristics with Treatment Initiation among Veterans with Stage I, II, or III Lung, Colon or Rectal Cancer [D] . Clary, Alecia S. 2019

机译：具有阶段I，II或III肺，结肠或直肠癌的退伍军人治疗发起的医院和患者特征
6. Randomized trial of two schedules of low-dose gemtuzumab ozogamicin as induction monotherapy for newly diagnosed acute myeloid leukemia in older patients not considered candidates for intensive chemotherapy. A phase II study of the EORTC and GIMEMA leukemia groups (AML-19) [O] . Sergio Amadori, Stefan Suciu, Dominik Selleslag, -1

机译：两次低剂量Gemtuzumab ozogamicin的随机试验作为新诊断的急性髓细胞白血病对老年患者的诱导单一的疗法而不是考虑到密集化疗的候选人。 EITTC和Gimema白血病组的II期研究（AML-19）
7. Symposium on diagnosis and treatment of cancer. Recent progress. II. Treatment of cancer. 1. Recent cancer chemotherapy. [O] . Kazuo OTA 1987

机译：癌症诊断和治疗研讨会。最近的进展。 II。治疗癌症。 1.近期癌症化疗。
8. THE CALCULATION OF TREATMENT SCHEDULES FOR CANCER CHEMOTHERAPY - PART II [R] . R. N. Stuart, T. C. Merkle 1965

机译：癌症化疗治疗方案的计算 - 第二部分

THE CALCULATION OF TREATMENT SCHEDULES FOR CANCER CHEMOTHERAPY. PART II,

著录项

相似文献

相关主题

期刊订阅